Pregabalin vs. Gabapentin on Reducing Opioid Usage

  • participants needed
  • sponsor
    CAMC Health System
Updated on 6 July 2022


This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with traditional opioid pain medications to decrease the amount of opioid pain medication usage in single-system orthopedic trauma patients.

Condition analgesic drugs, painkillers, anodyne, Wounds, Analgesics, pain medicine, Pain, analgesic, pain killers, narcotic, Pain (Pediatric), Wounds - qualifier, analgesic agents, injuries, Gabapentin, ache, Post-Surgical Pain, pain medication, Narcotics, Acute Pain Service, traumatic injury, Trauma, traumatic disorder
Treatment Pregabalin 50mg, Gabapentin 300mg, Neither Pregabalin nor Gabapentin
Clinical Study IdentifierNCT04705480
SponsorCAMC Health System
Last Modified on6 July 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note